Ronald D. Lawson, MD

1970 - 1973

Doctor of Medicine
The University of Tennessee,
Memphis, TN

1966 - 1970

Bachelor of Science in Zoology
The University of Tennessee at Knoxville
Knoxville, TN

7/78 – 6/79

Advanced Fellow & Instructor
Department of Developmental Therapeutics
MD Anderson Hospital and Tumor Institute
Houston, TX

7/77 – 6/78

Fellowship: Medical Oncology
University of Texas System Cancer Center
MD Anderson Hospital and Tumor Institute
Texas Medical Center, Houston, TX

1/75 – 6/77

Residency - Internal Medicine
Methodist Hospitals of Memphis,
Memphis, TN

1/74 – 12/74

Internship - Internal Medicine
Methodist Hospitals of Memphis
Memphis, TN

1981

American Board of Medical Oncology (65756)

1978

American Board of Internal Medicine (65756)

Tennessee State #08758

Arkansas State #R2983

6/15/09 – present

Hematology/ Oncology Physician
University of Tennessee Cancer Institute
Boston Baskin Cancer Group

2/05 – 6/14/09

Hematology/ Oncology Physician
The West Clinic, Memphis, TN

4/01 – 2/05

Boston Baskin Cancer Group, P.L.C.
1331 Union Avenue, Suite 800, Memphis, TN 38104
6005 Park Avenue, Suite 225B, Memphis, TN 38119
271 West Polk, West Memphis, AR 72301

1979 – 12/05

Methodist Hospitals of Memphis
1265 Union Avenue, Memphis, TN

1995 – 12/05

Senior Vice President, Medical Affairs and Clinical Services
Methodist Hospitals of Memphis, Memphis, TN

1982 – 4/01

Cancer Specialty Clinic, PLLC
1325 Eastmoreland, Ste. 370, Memphis, TN 38103

1992 – 1995

Vice President, Medical Affairs
Methodist Hospitals of Memphis, Memphis, TN

1989 – 1992

Associate Chief of Staff
Methodist Hospitals of Memphis, Memphis, TN

1989 – 1992

Chairman, Senior Leadership Council
Methodist Hospitals of Memphis, Memphis, TN

1980

Clinical Instructor in Medicine
Department of Internal Medicine
University of Tennessee

1979

Advanced Fellow and Instructor
University of Texas System
MD Anderson Cancer Center
Houston, TX

Alpha Epsilon Delta Honor Society

Clinical Fellow American Cancer Society

Member, American Society of Clinical Oncology

Member, Memphis, and Shelby County Medical Society

Member, Tennessee Medical Association

Member, American Society of Internal Medicine

Member, Memphis Academy of Internal Medicine

Fellow, American College of Physicians

1988 – 1991

Director, Internal Medicine and Transitional Training Programs
Medical Education Department
Methodist Hospitals of Memphis, Memphis, TN

1986 – 1991

Chairman, Infection Control Committee
Methodist Hospitals of Memphis, Memphis, TN

1986 – 1991

Chairman, Cancer Committee
Methodist Hospitals of Memphis, Memphis, TN

1985 – 1987

Chairman, Pharmacy and Therapeutics Committee
Methodist Hospitals of Memphis, Memphis, TN

1995

Editorial Review Board Member for Nursing Case Management Journal

1. “Systemic Hyperthermia for Advanced Malignancies.” Barlogie, Corry, Yip, Lippman, Johnston, Khalili, K., Tenczynski, Reilly, E., Lawson, R., Dosik, G., Rigor, B., Hankenson, R. and Freireich, E.; Cancer Treatment Rep. 39:1481 – 1489, 1979.

2. “Systemic Mycosis Due to Trichosporon Cutaneum.” Evans, H., Kletzel, M., Lawson, R., Frankel, L. and Hopfer, R.; Cancer. 45:367 – 371, 1980.

3. “Comparison of Clotrimazole and Nystatin in the treatment of Oropharyngeal Candidiasis.” Lawson, R., and Bodey, G. Current Therapeutic Research. 27:774 – 779, June 1980.

4. “Systemic Candidiasis as Manifested by Laryngitis.” Lawson, R., Bodey, G. and Lund, M.; Am. J. Med. Sci. 280:173 – 177, November 1980.

5. “Hormonal and Chemotherapy of Breast Cancer.” Ca-A Cancer Journal for Clinicians. May – June 1980.

6. “A New Schedule for the Administration of Tobramycin.” Lawson, R., Bodey, G., Pan T. and Smith, T.; Antimicrobial Agents and Chemotherapy. 17: 834 – 837, 1980.

7. “Combination Therapy with Ticarcillin and Sulfamethoxazole-Trimethoprim for Infections in Patients with Cancer.” Arch. Intern. Med. 141: 926 – 930.

8. “Ceftizoxime Treatment of Infection in Neutropenic Patients with Malignancies.” Lawson, R. and Baskin, R.; Journal of Antimicrobial Chemotherapy. 10, suppl. C, 159 – 165, 1982.

9. “A Randomized Study of Tobramycin Plus Ticarcillin, Tobramycin Plus Mezlocillin, or Tobramycin, Ticarcillin and Cephalothin in the Treatment of Infections in Neutropenic Patients with Malignancies.” Lawson, R., Bodey, G., Keating, M., Smith, T. and Gentry, L.; Am. J. Med. Sci. 287 (1): 1623, 1984.

10. “Multicenter Phase II Trial of Etoposide in Refractory Small Cell Lung Cancer.” Issell, B., Einhorn. L., Comsis, R., Lawson, R. Baker, L., Harver, H., Lanzotti, V., Wampler, G., Daniels, J., Anderson, P., Hong, W., Rentschler, R., Pikler, G., Maroun, J., Wernz, J. and Rosenbaum, P. Cancer Treatment Reports. Volume 69, Number1, 1 – 147, January 1985.

11. “Ticarcillin-Clavulanate Therapy for Infections with Ticarcillin-Resistant Microorganisms.” Gelfand, M., Lawson, R. and Baucom, W.; Southern Medical Journal. Volume 82, Number 4, 433 – 437, April 1989.

12. “Etoposide Combined with Cyclophosphamide Plus Vincristine Compared with Doxorubicin Plus Cyclophosphamide Plus Vincristine in the treatment of Small Cell Carcinoma of the Lung: A Randomized Trial of the Bristol Lung Cancer Study Group.” Hong, W., Nicaise, C. Lawson, R., Maroun, J., Comis, R., Speer, J., Luedke, D., Hurtubise, M., Lanzotti, V., Goodlow, J. and Rozencweig, M.; Journal of Clinical Oncology. Volume 7, Number 4, 450 – 56, April 1989.

13. “Sharing Financial Information with Doctors: Making It Work.” Lawson, R.; Journal for Healthcare Quality. July – August 1993.

14. “Small Hospitals Explore CQI Without Computer Data Systems.” Lawson, R.; QI/TQM. July 1994.

15. Implementing an Integrated Program of Resource Management.” Lawson, R.; Journal for Healthcare Quality. May/June 1995.

16. “Reducing Variation in Clinical Resource Use: Doctors, Data, Decision Making.” Lawson, R., Mitchell, K., Richter, E. and Kritchevsky, S.; In Preparation.

1. “Infections in Patients Undergoing Bone Marrow Transplantation.” Blood. November 1978.

2. “Antibiotic Combinations in the Treatment of Infections in Cancer Patients.” Proc. Am. Soc. Clin. Oncol. 1979.

3. “The Use of the Protected Environment and the Treatment of Patients with Cancer.” Journal for Practitioners in Infection Control.

4. “Antibiotic Combination in the Treatment of Infection in Cancer Patients.” Interscience Conference on Antimicrobial Agents and Chemotherapy. October 1979.

5. Hydrocele in Patients with Hodgkin’s Disease.” Proc. Am. Soc. Clin. Oncol. 1981.

6. “Ceftizoxime Therapy for Febrile Neutropenic Patients.” Interscience Conference on Antimicrobial Agents and Chemotherapy. November 1981.

7. “Cytoxan, Etoposide and Vincristine versus Cytoxan, Adriamycin and Vincristine or Cytoxan and Vincristine in the Treatment of Small Cell Carcinoma of Lung Cancer.” Proc. Am. Soc. Clin. Oncol. 1987.

1. “Sharing Financial Information with Doctors,” HealthTrust Regional Consultants, Dallas, Texas, March 31, 1993.

2. “Involving Physicians with Optimizing Hospital Resource,” Methodist Medical Center Medical Staff, Jackson, Mississippi, May 25, 1993.

3. “The Impact of Healthcare Reform Attempts upon the Medical Community,” Memorial Mission Medical Center, Asheville, NC, July 16, 1993.

4. “The Impact of Healthcare Reform Attempts upon the Medical Community,” Urology Update Conference, Memphis, Tennessee, July 17, 1993.

5. “Role of Physicians in Case Management,” HealthTrust Southern Region, Dallas, Texas, July 23, 1993.

6. “Profiling Doctors: Sharing Utilization Data with Physicians to Change Practice Patterns,” MHM Management Seminar, Fogelman Executive Center, Memphis, Tennessee, August 12, 1993.

7. “Effect of MHM Utilization Management Program,” MHM-North Medical Staff, Memphis, Tennessee, August 26, 1993.

8. “Designing an Integrated Utilization Program,” Summer Workshop of the HFMA, Jackson, MS, August 27, 1993.

9. “Using Chart Review to Optimize Patient Length of Stay” and “Early Physician Involvement in the Development of Clinical Pathways,” 18th Annual Educational Conference for NAHQ, New York, NY, September 20, 1993.

10. “Profiling Doctors: Sharing Utilization Data with Physicians to Change Practice Patterns,” HealthTrust Southeast Region, Miami, FL, October 8, 1993.

11. “Sharing Financial Information with Doctors: Making It Work,” HealthTrust Physician Advisors, Charlotte, NC, October 12, 1993.

12. “Effectiveness of Treating Cancer Patients, “ ONS Group, Memphis Chapter, Memphis, TN, October 21, 1993.

13. “Profiling Doctors: Sharing Utilization Data with Physicians to Change Practice Patterns,” HealthTrust Physician Advisors, Houston, TX, November 4-5, 1993.

14. “Sharing Financial Information with Doctors: Making It Work,” TAHQ, Nashville, TN, November 12, 1993.

15. “Profiling Doctors: Sharing Utilization Data with Physicians to Change Practice Patterns,” HealthTrust Southern Region, New Orleans, LA, November 12-13, 1993.

16. “Designing an Integrated Utilization Management Program,” HealthTrust Eastern Region, Charlotte, NC, May 14, 1994.

17. “Impact on Tenncare and Other Local Initiatives,” HealthTrust Mid-South Region Physician/Advisor Management Meeting, Hilton Head, SC, August 26, 1994.

18. “Physician Practice and Case Management,” National Association for Healthcare Quality, 19th Annual Educational Conference, Reno, NV, October 4, 1994.

19. “Resource Utilization and Quality Monitoring in Managed Care,” Medial Reviews for Primary Care Physicians Conference, Amelia Island, FL July 20-22, 1995.

20. “How to Share Practice Pattern Data with Physicians,” Columbia/HCA Healthcare Corporation, Carolina Division Meeting, Charlotte, NC, April 26, 1996